Here are four stocks Fortune recommends for those interested in investing in healthcare.
- Alnylam Pharmaceuticals, which saw its shares rise 259 percent this year after promising clinical trials for one of its experimental drugs being used to treat hereditary ATTR amyloidosis.
- Sage Therapeutics, which may become the first company to market a drug to treat postpartum depression.
- UnitedHealth Group, who analysts expect an average 13.5 percent earnings growth rate for the insurer over the next five years.
- Intuitive Surgical, a medical device manufacturer leading the way in robotic-assisted surgery.
More articles on healthcare finance:
10 grants, donations to healthcare organizations in November
10 recent hospital, health system outlook and credit rating actions
Jackson Health System posts a profit for 6th consecutive year
